| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
146,000,000 |
| Market
Cap: |
15.86(B) |
| Last
Volume: |
1,605,892 |
Avg
Vol: |
1,353,529 |
| 52
Week Range: |
$92.79 - $209.935 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 11.4 |
| Insider 3/6 Months : 12 |
|
| Guru Rank Number : 691 |
| Guru Rank Value : 2.3 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
7,330 |
7,330 |
7,330 |
| Total Buy Value |
$0 |
$991,672 |
$991,672 |
$991,672 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
1,815 |
22,740 |
| Total Sell Value |
$0 |
$0 |
$314,105 |
$4,648,975 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
4 |
17 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ostadan Omead |
SVP Mktg, Prod & Strat Plan |
• • – |
2019-02-15 |
4 |
AS |
$294.56 |
$371,216 |
D/D |
(1,260) |
29,420 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2019-02-13 |
4 |
AS |
$293.66 |
$969,078 |
D/D |
(3,300) |
344,868 |
|
- |
|
| Van Oene Mark |
SVP Chief Commercial Officer |
• • – |
2019-02-12 |
4 |
D |
$292.20 |
$842,120 |
D/D |
(2,882) |
14,834 |
|
- |
|
| Van Oene Mark |
SVP Chief Commercial Officer |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,185 |
15,997 |
|
- |
|
| Van Oene Mark |
SVP Chief Commercial Officer |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,639 |
15,419 |
|
- |
|
| Ostadan Omead |
SVP Mktg, Prod & Strat Plan |
• • – |
2019-02-12 |
4 |
D |
$292.20 |
$1,516,226 |
D/D |
(5,189) |
30,680 |
|
- |
|
| Ostadan Omead |
SVP Mktg, Prod & Strat Plan |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,994 |
35,869 |
|
- |
|
| Ostadan Omead |
SVP Mktg, Prod & Strat Plan |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,492 |
33,875 |
|
- |
|
| Ronaghi Mostafa |
SVP & CTO |
• • – |
2019-02-12 |
4 |
D |
$292.20 |
$1,568,237 |
D/D |
(5,367) |
77,414 |
|
- |
|
| Ronaghi Mostafa |
SVP & CTO |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,055 |
80,188 |
|
- |
|
| Ronaghi Mostafa |
SVP & CTO |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,782 |
79,217 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2019-02-12 |
4 |
D |
$292.20 |
$4,166,188 |
D/D |
(14,258) |
79,746 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,171 |
84,614 |
|
- |
|
| Desouza Francis A |
President and CEO |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,621 |
82,910 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2019-02-12 |
4 |
D |
$292.20 |
$4,917,142 |
D/D |
(16,828) |
348,168 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,067 |
364,996 |
|
- |
|
| Flatley Jay T |
Director |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,888 |
358,929 |
|
- |
|
| Ragusa Robert P |
SVP, Global Quality & Ops |
• • – |
2019-02-12 |
4 |
D |
$292.20 |
$649,268 |
D/D |
(2,222) |
14,048 |
|
- |
|
| Ragusa Robert P |
SVP, Global Quality & Ops |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
954 |
16,270 |
|
- |
|
| Ragusa Robert P |
SVP, Global Quality & Ops |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,540 |
15,316 |
|
- |
|
| Dadswell Charles |
SVP & General Counsel |
• • – |
2019-02-12 |
4 |
D |
$292.20 |
$576,803 |
D/D |
(1,974) |
9,957 |
|
- |
|
| Dadswell Charles |
SVP & General Counsel |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
867 |
11,931 |
|
- |
|
| Dadswell Charles |
SVP & General Counsel |
• • – |
2019-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,127 |
11,064 |
|
- |
|
| Siegel Susan E |
Director |
• • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,839 |
2,839 |
|
- |
|
| Dadswell Charles |
SVP & General Counsel |
• • – |
2019-02-01 |
4 |
AS |
$280.11 |
$34,734 |
D/D |
(124) |
6,879 |
|
- |
|
1655 Records found
|
|
Page 22 of 67 |
|
|
0.56 (0.51%) 
